(analytical variance)I associated with the GCT for women in the same or consecutive pregnancies and to assess the implications for potential patient misclassification.
Materials and Methods
The subjects were selected from our records of 2708 individual women who, over a 3-year period, had attended the Maternity Outpatient Clinic for a routine GCT between 24 and 28 weeks of gestation. The study met the precepts of the Hospital Ethics Committee.
All women who had two pregnancies either 1 or 2 years apart formed the study cohort. The first group comprised 77 women who had a GCT in each of consecutive pregnancies -1 year apart. A second group of 43 women had GCTs in consecutive pregnancies -2 years apart. For the third group, pregnant women who had GCTs on consecutive days, data were calculated directly
enlarging the diagram so that the potential error in transcribing data points was minimized to <1 mg/dL; only those data pairs (n = 53) were selected where no ambiguity existed with respect to their identity. The day I and day 2 means for the selected subjects (n = 53) and for the full set (n = 80) were similar (Ill vs 108 mg/dL for day I and 110 vs 107 mg/dL for day 2), suggesting that no major selection bias was introduced. Within the total group of pregnant women with two GCTs (n = 173), 9.2% had one of the two GCT values l40 mg/dL, and 5.2% had both values above the threshold.
The SO-g glucose (anhydrous) load was administered to nonfasting women as a carbonated lime-flavored beverage (300 [5, 6] . In the present work, 5000 bootstrap samples were randomly drawn (with replacement) from each of the three groups' set of variances, such that the number of selections equaled the number of observations; the respective mean was calculated for each of these 5000 sets, and the estimated mean was taken as the median of the bootstrap cumulative distribution function. The standard error was calculated as half the central 67% interval of values in the distribution of bootstrap means. As a further extension to ensure that the estimation of the mean was not affected by extreme values, for each bootstrap sample selected, values more than ± 1.5 SDs from the initially calculated mean were eliminated and a new "trimmed" mean was determined [5] .
In Bayesian statistics, the true GCT value for a subject is unknown but has an assumed prior distribution with mean u and variance 02,, for a specified population.
Results for a subject's repeat tests will vary over time due to o.. This allows calculation of the respective confidence interval for a single measurement as R x,,,,
where R = is the reliability of the observed measurement and z is the Z-statistic [7, 8] . Thus knowledge of GCT values in the given population allows the Bayesian approach to produce a tighter confidence interval than obtained by the classical approach (x,,h5 ± z \/02). However (as noted by one of the reviewers of this paper), although the Bayesian approach on average is unbiased and more precise, there will be rare occasions when the original observation corresponds to the individual's true mean and adjusting towards the population mean will result in a less accurate estimation.
Results
The overall findings for the three groups of pregnant women are summarized in Table 1 . First, there was no significant difference, with respect to the gestational age at which GCTs were performed, for consecutive pregnancies in either group 1 or group 2 (paired t-test, P >0.6). Second, the average gestational n for all women on record (n = 2708).
There was also no significant difference between the GCT means for the three groups (Mann-Whitney U-test, P >0.35).
Within each group, no statistically significant change occurred between the test-retest 1-h plasma glucose results (paired t-test,
The estimated values of log,002 show that the short-term (group 3, intrapregnancy) and long-term (groups 1 and 2, interpregnancy)
GCT reproducibility is comparable (Table 1) ; this is confirmed by the lack of significant difference of variances between the three groups (Mann-Whitney U-test, P >0.46).
O'Sullivan
and Mahan [9] , testing the variability of the 3-h 1OO-g oral glucose tolerance test (OGTT) during three consecutive pregnancies, also found that the variation due to time was minimal. Accordingly, the three groups could be combined (n = 173) and the overall log,1102 was calculated to be 0.0033204 ± 0.0003 5. Moreover, the mean GCT value was shown to be independent of the respective variance (Spearman r = -0.13,
The population mean (.t) and variance for the normally distributed log,0GCT values (n = 2695) were calculated as 2.00710 (102 mg/dL) and 0.0100952, respectively; 02,, was therefore estimated to be 0.0067 748 and the coefficient o reliability (R) for repeat measurements 0.67 1. These parameters were in turn used to calculate the percentage probability that the true GCT value, for any observed value (x01,.), would be equal to or greater than the 140 mg/dL threshold by solving the equations described above for the Z-statistic (Fig. 1 ).
Discussion
The results show that the short-term (intrapregnancy) an long-term (interpregnancy)variabilities of the GCT, for th same individual, are comparable, if the test is done at about th same gestational age (Table 1) . Furthermore, 02,, rather than 02 is the main contributor to total population variance, as indicate by the coefficient of reliability (0.67 1). In contrast, O'Sulliva and Mahan [9] reported that the reliability of determination fo women undergoing a 3-h 100-g OGTT' in three successiv pregnancies was only 0.29 for the 1-h plasma glucose concentration, and the absolute 02,, was some sevenfold higher than that for the respective fasting value. The present findings establish that a woman with an observed GCT of s125 mg/dL has a <5% probability of having a true value 140 mg/dL (Fig. 1) . Consequently, asymptomatic pregnant women with no risk factors, and with a prior GCT of <125 mg/dL, may not require testing in a subsequent pregnancy, at least within 2 years. However, because glucose intolerance is known to increase with maternal age, particularly after age 30 years [10] , younger women (<25 years) would represent the most appropriate group for minimal retesting in subsequent )regnancies.
The <5% probability associated with a GCT of 125 mg/dL Fig. 1 The help and assistance of S.K. James and Cj. Seahorn in the database compilation is gratefully acknowledged.
